Study of usefulness of whole body low dose CT scan to detect bone metastasis in breast cancer
Not Applicable
Completed
- Conditions
- Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
- Registration Number
- CTRI/2021/11/038104
- Lead Sponsor
- All India Institute of Medical Sciences New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 110
Inclusion Criteria
Patients with carcinoma breast with primary tumor size of 5cm or more, biopsy or FNAC proven axillary lymph node metastasis, AJCC TNM Stage III (anatomic staging), AJCC TNM Stage IV (anatomic staging), patients of any stage having symptoms or biochemical abnormality which could be attributable to metastasis, treated cases of carcinoma breast suspected of developing metastasis
Exclusion Criteria
Pregnant women, non consenting patients, Patient with history of allergy to iodinated contrast and those with deranged Kidney function test will undergo non contrast CT scan and will be evaluated only for the primary objective
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Detection of bony metastasis in Whole Body LDCT as compared to skeletal scintigraphy <br/ ><br>Timepoint: Baseline <br/ ><br>
- Secondary Outcome Measures
Name Time Method Detection of pulmonary, visceral and nodal metastasis in LDCT compared to CD CT <br/ ><br>Timepoint: Baseline <br/ ><br>